International Business Today Autumn 2017
Welcome to the autumn edition of International Business Today – our first for 2017. In this edition we explore the Netherlands: the gateway to Europe.
So dust off those old wooden clogs and break out the crackers and Dutch Gouda as Niels Strazdins gives you a special insight into this tiny powerhouse,
strategically located between Europe’s two biggest continental economies. Niels explains why the Netherlands is now one of the hottest start-up hubs
in Europe – and identifies opportunities for Australian exporters. The country provides an ideal place for Australian entrepreneurs and start-ups to
begin their international journey.
Closer to home, Niels looks at the growing trade opportunities with the 10 nations that make up the Association of Southeast Asian Nations (ASEAN) – collectively one of the fastest-growing regions of the world. And although Australia now enjoys a strong trading relationship with our neighbours to the north, there is still plenty of scope to expand. The region is home to over 600 million people and a fast-growing middle class that is predicted to more than double in under a decade.
Also in this issue, our Postcard series focuses on Myanmar and identifies new opportunities for exporters in this emerging market. Readers are given a guided tour of Yangon, the former capital of Myanmar, with tips on the best places to visit if you can find some spare time between business
Tim Michael, Editor
Become A Member
Co-Founder & Commercial Director,
Pharmako Biotechnologies Pty Ltd
Member of the ECA
"Pharmako Biotechnologies were already exporting when we joined the ECA. We joined to assist our export strategies, and unashamedly to promote ourselves
through the Australian Export Awards. As a small business, third party recognition and industry membership assist when dealing with large
Established in 1970, Mavlab Animal Health Pty Ltd is a Queensland based, family-owned, GMP licenced manufacturer of veterinary pharmaceuticals and pet care products. Mavlab has an extensive range of prescription and over the counter products sold in a growing number of global markets. Contract manufacturing opportunities are also available.